Lonza's stem cell production insight a boon to innovation and business
Investments in manufacturing and science have left Lonza well placed to cope with skyrocketing demand for stem cell manufacturing, the CMO says.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs